This report was developed by the American Speech-Language-Hearing Association (ASHA) and the American Academy of Otolaryngology-Head and Neck Surgery (AAO-HNS). It was developed by the AAO-HNS Speech, Voice and Swallowing Committee—Robert Sataloff, Jonathan Aviv, Mary Beaver, Alison Behrman (ASHA representative), Mark Courey, Glendon Gardner, Norman Hogikyan, Christy Ludlow (ASHA representative), Roger Nuss, Clark Rosen, Mark Shikowitz, Robert Stachler, Lee Akst, and Susan Sedory Holzer (staff liaison), and by ASHA Special Interest Division 3, Voice and Voice Disorders Steering Committee members, Leslie Glaze (coordinator), Bernice Klaben, Lori Lombard, Mary Sandage (associate coordinator), Susan Thibeault, and Michelle Ferketic (ex officio). Celia Hooper, vice president for professional practices (2003–2005), served as monitoring vice president for ASHA.
Dysphonia is defined as an impairment of the speaking or singing voice. Dysphonia arises from an abnormality of the structures and or functions of the voice production system and can cause bodily pain, a personal communication disability, and an occupational or social handicap. The cause of dysphonia is generally multifactorial. Genetic factors may predispose an individual to voice disorders (Gray, Hammond, & Hanson, 1995). Chronic and acute variables may precipitate dysphonia. These include occupational vocal demands, medications, health problems, environment, physical trauma, and lifestyle choices. Dysphonia is as disruptive to quality of life as angina, sciatica, and chronic sinusitis (Benninger, Ahuja, Gardner, & Grywalski, 1998). The communicative problems associated with dysphonia can lead to social withdrawal, occupational handicaps, and depression (E. Smith et al., 1996).
Voice disorders are a widespread and significant problem. Estimates of prevalence range from 3% to 7% of the general population (Healy, Ackerman, Chappell, Perrin, & Stormer, 1981). Individuals with heavy occupational voice use, a significant risk factor for dysphonia, may comprise from 5%–10% of the U.S. workforce (Titze, Lemke, & Montequin, 1997). The largest epidemiologic study of the prevalence of voice disorders in the United States (Roy et al., 2004) revealed that approximately 43% of adults surveyed experienced voice problems at some point during their life. Approximately 23% of those individuals visited a physician or speech-language pathologist for treatment for dysphonia. The cost of untreated voice disorders total billions of dollars in treatment and lost productivity costs (Ramig & Verdolini, 1998). In teachers alone, the cost of dysphonia approaches $2.67 billion annually in the United States (Verdolini & Ramig, 2001).
The overall goal for the patient with dysphonia is optimal long-term voice quality and communication function with minimal recurrence. Diagnosis and treatment should be both efficient and effective. Voice therapy is an integral component of intervention and contributes to both its efficacy and efficiency. Evidence from clinical trials documents the efficacy of voice therapy for a spectrum of voice disorders in both adults and children (Bassiouny, 1998; Boone, 1974; MacKenzie Millar, Wilson, Sellars, & Deary, 2001; Roy et al., 2001; Sellars, Carding, Deary, MacKenzie, & Wilson, 2002; Speyer, Wieneke, & Dejonckere, 2004; Verdolini-Marston, Burke, Lessac, Glaze, & Caldwell, 1995; Xu, Ikeda, & Komiyama, 1991). Even in patients with a long history of dysphonia, voice therapy can be highly effective (Speyer et al., 2004). Efficiency includes cost-effective and prompt intervention provided over a time period most suitable for achieving optimal outcome.
Voice therapy is the treatment of choice for muscle tension dysphonia and there is evidence to support its utility in these cases (Andrews, Warner, & Stewart, 1986; Carding, Horsley, & Docherty, 1999; Fex, Fex, Shiromoto, & Hirano, 1994; Kitzing & Akerlund, 1993; Maryn, De Bodt, & Van Cauwenberge, 2003; Roy, Bless, Heisey, & Ford, 1997). In complex disorders, such as paradoxical vocal fold motion, voice therapy prevents long-term costs of treatment by helping reduce expensive emergency room visits and hospitalizations (Bastian, 1987; Boone & McFarlane, 1988; Kotby, Shiromoto, & Hirano, 1993; Martin, Blager, Gay, & Wood, 1987; Stemple, Lee, D'Amicco, & Pickup, 1994).
Benign vocal fold lesions are a common cause of dysphonia (Gould, Rubin, & Yanagisawa, 1995). Most laryngologists consider voice therapy, often together with medical management, the initial treatment of choice for benign lesions (Anderson & Sataloff, 2002; Garrett & Ossoff, 2000; Pedersen, Beranova, & Moller, 2004; Sulica & Behrman, 2003). Many studies have documented excellent outcomes after voice therapy in patients with a variety of benign lesions (Blood, 1994; Gordon, Pearson, Paton, & Montgomery, 1997; Holmberg, Hillman, Hammarberg, Sodersten, & Doyle, 2001; Lancer, Syder, Jones, & Le Boutillier, 1988; McCrory, 2001; Murry & Woodson, 1992; S. Smith & Thyme, 1976; Speyer et al., 2002; Verdolini-Marston et al., 1995; Ylitalo & Hammarberg, 2000). Increasingly, otolaryngologists are using response to voice therapy to help differentiate among benign mucosal lesions, inform the treatment decision for surgery, and optimize surgical outcome. In cases in which surgery is necessary, pre- and postoperative voice therapy may shorten the postoperative recovery time, allowing faster return to work and limiting scar tissue and permanent dysphonia (Woo, Casper, Colton, & Brewer, 1994).
Most laryngologists consider voice therapy essential for patients with unilateral vocal fold paralysis as definitive treatment or as adjunctive to surgery (Benninger et al., 1994). Evidence suggests that preoperative voice therapy improves voice outcomes for greater than 50% of patients with unilateral vocal fold paralysis and may render surgery unnecessary (Heuer et al., 1997). In other neurological-based dysphonia, such as Parkinson's disease, voice therapy has yielded significant improvement in overall communication (de Angelis et al., 1997; Ramig, Countryman, O'Brien, Hoehn, & Thompson, 1996; M. E. Smith, Ramig, Dromey, Perez, & Samandari, 1995; Spielman, Borod, & Ramig, 2003).
In conclusion, research data and expert clinical experience support the use of voice therapy in the management of patients with acute and chronic voice disorders. Voice therapy contributes to increased effectiveness and efficiency in the treatment of voice disorders. When surgery is necessary, adjuvant voice therapy can improve surgical outcomes, prevent additional injury, and limit additional treatment costs.
Anderson, T., & Sataloff, R. T. (2002). The power of voice therapy. Ear Nose and Throat Journal, 81, 433–434.
Andrews, S., Warner, J., & Stewart, R. (1986). EMG biofeedback and relaxation in the treatment of hyperfunctional dysphonia. British Journal of Disorders of Communication, 21, 353–369.
Bassiouny, S. (1998). Efficacy of the accent method of voice therapy. Folia Phoniatrica et Logopedica, 50, 146–164.
Benninger, M. S., Ahuja, A. S., Gardner, G., & Grywalski, C. (1998). Assessing outcomes for dysphonic patients. Journal of Voice, 12, 540–550.
Benninger, M. S., Crumley, R. L., Ford, C. N., Gould, W. J., Hanson, D. G., Ossoff, R. H., & Sataloff, R. T. (1994). Evaluation and treatment of the unilateral paralyzed vocal fold. Otolaryngology-Head and Neck Surgery, 111, 497–508.
Boone, D. R. (1974). Dismissal criteria in voice therapy. Journal of Speech and Hearing Disorders, 39, 133–139.
Boone, D. R., & McFarlane, S. C. (1988). A critical view of the yawn-sigh as a voice therapy technique. Journal of Voice, 7, 75–80.
Carding, P. N., Horsley, I. A., & Docherty, G. J. (1999). A study of the effectiveness of voice therapy in the treatment of 45 patients with nonorganic dysphonia. Journal of Voice, 13, 72–104.
de Angelis, E. C., Mourao, L. F., Ferraz, H. B., Behlau, M.S., Pontes, P.A., & Andrade, L. A. (1997). Effect of voice rehabilitation on oral communication of Parkinson's disease patients. Acta Neurologica Scandinavica, 96, 199–205.
Fex, B., Fex, S., Shiromoto, O., & Hirano, M. (1994). Acoustic analysis of functional dysphonia: Before and after voice therapy (accent method). Journal of Voice, 8, 163–167.
Garrett, C. G., & Ossoff, R. H. (2000). Phonomicrosurgery II: Surgical techniques. Otolaryngology Clinics of North America, 33, 1063–1070.
Gordon, M. T., Pearson, L., Paton, F., & Montgomery, R. (1997). Predictive assessment of vocal efficacy (PAVE): A method for voice therapy outcome measurement. Journal of Laryngology and Otology, 3, 129–133.
Gould, W. J., Rubin, J. S., & Yanagisawa, E. (1995). Benign vocal fold pathology through the eyes of the laryngologist. In J. S. Rubin, R. Sataloff, G. Korovin, & W. J. Gould (Eds.), Diagnosis and treatment of voice disorders (pp. 137–151). New York: Igaku-Shojin.
Gray, S. D., Hammond, E., & Hanson, D. F. (1995). Benign pathologic responses of the larynx. Annals of Otology, Rhinology & Laryngology, 104, 13–18.
Healy, W. C., Ackerman, B. L., Chappell, C. R., Perrin, K. L., & Stormer, J. (1981). The prevalence of communicative disorders: A review of the literature. Rockville, MD: American Speech-Language-Hearing Association.
Heuer, R. J., Sataloff, R. T., Emerich, K., Rulnick, R., Baroody, M., Spiegel, J. R., et al. (1997). Unilateral recurrent laryngeal nerve paralysis: The importance of “preoperative” voice therapy. Journal of Voice, 11, 88–94.
Holmberg, E. B., Hillman, R. E., Hammarberg, B., Sodersten, M., & Doyle, P. (2001). Efficacy of a behaviorally based voice therapy protocol for vocal nodules. Journal of Voice, 15, 395–412.
Kitzing, P., & Akerlund, L. (1993). Long-time average spectrograms of dysphonic voices before and after therapy. Folia Phoniatrica, 45, 53–61.
Kotby, M. N., Shiromoto, O., & Hirano, M. (1993). The accent method of voice therapy: Effect of accentuations on F0, SPL, and airflow. Journal of Voice, 7, 319–325.
Lancer, M., Syder, D., Jones, A. S., & Le Boutillier, A. (1988). The outcome of different management patterns for vocal cord nodules. Journal of Laryngology and Otology, 102, 423–432.
MacKenzie, K., Millar, A., Wilson, J. A., Sellars, C., & Deary, I. J. (2001). Is voice therapy an effective treatment for dysphonia? A randomised controlled trial. British Medical Journal, 323, 658–661.
Martin, R. J., Blager, F. B., Gay, M. L., & Wood, R. P. (1987). Paradoxic vocal cord motion in presumed asthmatics. Seminars in Respiratory Medicine, 8, 332–337.
Maryn, Y., De Bodt, M. S., & Van Cauwenberge, P. (2003). Ventricular dysphonia: Clinical aspects and therapeutic options. Laryngoscope, 113, 859–866.
McCrory, E. (2001). Voice therapy outcomes in vocal fold nodules: A retrospective audit. International Journal of Language & Communication Disorders, 36(Suppl.), 19–24.
Murry, T., & Woodson, G. E. (1992). A comparison of three methods for the management of vocal fold nodules. Journal of Voice, 6, 271–276.
Pedersen, M., Beranova, A., & Moller, S. (2004). Dysphonia: Medical treatment and a medical voice hygiene advice approach. A prospective randomised pilot study. European Archives of Oto-Rhino-Laryngology, 261, 312–315.
Ramig, L. O., Countryman, S., O'Brien, C., Hoehn, M., & Thompson, I. (1996). Intensive speech treatment for patients with Parkinson disease: Short- and long-term comparison of two techniques. Neurology, 47, 1496–1504.
Ramig, L. O., & Verdolini, K. (1998). Treatment efficacy: Voice disorders. Journal of Speech, Language, and Hearing Research, 41, S101–S116.
Roy, N., Bless, D. M., Heisey, D., & Ford, C. N. (1997). Manual circumlaryngeal therapy for functional dysphonia: An evaluation of short- and long-term treatment outcomes. Journal of Voice, 11, 321–331.
Roy, N., Gray, S. D., Simon, M., Dove, H., Corbin-Lewis, K., & Stemple, J. C. (2001). An evaluation of the effects of two treatment approaches for teachers with voice disorders: A prospective randomized clinical trial. Journal of Speech, Language, and Hearing Research, 44, 286–296.
Roy, N., Merrill, R. M., Thibeault, S., Parsa, R. A., Gray, S. D., & Smith, E. M. (2004). Prevalence of voice disorders in teachers and the general population. Journal of Speech, Language, and Hearing Research, 47, 281–293.
Sellars, C., Carding, P. N., Deary, I. J., MacKenzie, K., & Wilson, J. A. (2002). Characterization of effective primary voice therapy for dysphonia. Journal of Laryngology & Otology, 116, 1014–1018.
Smith, E., Verdolini, K., Gray, S., Nichols, S., Lemke, J., Barkmeier, J., et al. (1996). Effect of voice disorders on quality of life. Journal of Medical Speech-Language Pathology, 4, 223–244.
Smith, M. E., Ramig, L. O., Dromey, C., Perez, K. S., & Samandari, R. (1995). Intensive voice treatment in Parkinson disease: Laryngostroboscopic findings. Journal of Voice, 9, 453–459.
Smith, S., & Thyme, K. (1976). Statistic research on changes in speech due to pedagologic treatment (the accent method). Folia Phoniatricia, 28, 98–103.
Speyer, R., Wieneke, G. H., & Dejonckere, P. H. (2004). Documentation of progress in voice therapy: Perceptual, acoustic, and laryngostroboscopic findings pretherapy and posttherapy. Journal of Voice, 18, 325–340.
Speyer, R., Weineke, G., Hosseini, E. G., Kempen, P. A., Kersing, W., & Dejonckere, P. H. (2002). Effects of voice therapy as objectively evaluated by digitized laryngeal stroboscopic imaging. Annals of Otology, Rhinology & Laryngology, 111, 902–908.
Spielman, J. L., Borod, J. C., & Ramig, L. O. (2003). The effects of intensive voice treatment on facial expressiveness in Parkinson disease: Preliminary data. Cognitive & Behavioral Neurology, 16, 177–188.
Stemple, J. C., Lee, L., D'Amico, B., & Pickup, B. (1994). Efficacy of vocal function exercises as a method of improving voice production. Journal of Voice, 8, 270–278.
Sulica, L., & Behrman, A. (2003). Management of benign vocal fold lesions: A survey of current opinion and practice. Annals of Otology, Rhinology & Laryngology, 112, 827–833.
Titze, I. R., Lemke, J., & Montequin, D. (1997). Populations in the U.S. workforce who rely on voice as a primary tool of trade: A preliminary report. Journal of Voice, 11, 254–259.
Verdolini, K., & Ramig, L. (2001). Review: Occupational risks for voice problems. Logopedics, Phoniatrics, and Vocology, 26, 37–46.
Verdolini-Marston, K., Burke, M. K., Lessac, A., Glaze, L., & Caldwell, E. (1995). Preliminary study of two methods of treatment for laryngeal nodules. Journal of Voice, 9, 74–85.
Woo, P., Casper, J., Colton, R., & Brewer, D. (1994). Diagnosis and treatment of persistent dysphonia after laryngeal surgery: A retrospective analysis of 62 patients. Laryngoscope, 104, 1084–1091.
Xu, J. H., Ikeda, Y., & Komiyama, S. (1991). Bio-feedback and the yawning breath pattern in voice therapy: A clinical trial. Auris, Nasus, Larynx, 18, 67–77.
Ylitalo, R., & Hammarberg, B. (2000). Voice characteristics, effects of voice therapy, and long-term follow-up of contact granuloma patients. Journal of Voice, 14, 557–566.
Index terms: voice, treatment, dysphonia
Reference this material as: American Speech-Language-Hearing Association. (2005). The use of voice therapy in the treatment of dysphonia [Technical Report]. Available from www.asha.org/policy.
© Copyright 2005 American Speech-Language-Hearing Association. All rights reserved.
Disclaimer: The American Speech-Language-Hearing Association disclaims any liability to any party for the accuracy, completeness, or availability of these documents, or for any damages arising out of the use of the documents and any information they contain.